SPECTRUM PHARMACEUTICALS INC's ticker is and the CUSIP is 84763AAB4. A total of 7 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $9,510,000 | -99.9% | 4,740,000 | -9.2% | 1.47% | +13.6% |
| Q1 2018 | $8,115,064,000 | -55.4% | 5,220,000 | -47.1% | 1.29% | -55.9% |
| Q4 2017 | $18,214,279,000 | +29.2% | 9,860,000 | -4.3% | 2.93% | +19.6% |
| Q3 2017 | $14,097,858,000 | +32.9% | 10,305,000 | +2.8% | 2.45% | +22.2% |
| Q2 2017 | $10,606,651,000 | +5.7% | 10,025,000 | +0.1% | 2.00% | +2.8% |
| Q1 2017 | $10,035,726,000 | +41.3% | 10,010,000 | +25.2% | 1.95% | +32.8% |
| Q4 2016 | $7,101,879,000 | -3.0% | 7,995,000 | -2.3% | 1.47% | -4.3% |
| Q3 2016 | $7,320,107,000 | -2.1% | 8,185,000 | -0.8% | 1.53% | -10.6% |
| Q2 2016 | $7,474,872,000 | -1.0% | 8,250,000 | +2.5% | 1.72% | -5.5% |
| Q1 2016 | $7,547,261,000 | +105249.8% | 8,050,000 | -1.9% | 1.82% | -2.7% |
| Q4 2015 | $7,164,000 | -11.8% | 8,205,000 | -9.2% | 1.87% | -24.1% |
| Q3 2015 | $8,122,000 | – | 9,035,000 | – | 2.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 4,969,000 | $5,168,000 | 3.68% |
| Sonora Investment Management, LLC | 10,025,000 | $10,606,651,000 | 2.00% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 16,000,000 | $16,914,000 | 1.55% |
| ASHFORD CAPITAL MANAGEMENT INC | 2,003,000 | $2,121,000 | 0.37% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,272,000 | $17,985,000 | 0.27% |
| OAKTREE CAPITAL MANAGEMENT LP | 9,119,000 | $9,693,000 | 0.16% |
| WOLVERINE ASSET MANAGEMENT LLC | 10,000,000 | $10,502,000 | 0.13% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 750,000 | $798,000 | 0.08% |
| Citadel Advisors | 11,450,000 | $12,031,000 | 0.01% |
| FMR LLC | 10,150,000 | $10,746,000 | 0.00% |